SESSION XIII: CELLULAR THERAPY
Session Chairs: Roni Shouval, MD, PhD and Sairah Ahmed, MD
Multimodal Approach to Predict Cellular Therapy Outcome | Roni Shouval, MD, PhD | Memorial Sloan Kettering Cancer Center, New York, New York, USA
AI Agents Transforming Care in Bone Marrow Transplantation | Amin Turki, MD, PhD | University of Essen, Essen, Germany
Debate: Car T Cells Are the Best Strategy for Relapsed DLBCL | Yi Lin, MD, PhD | Mayo Clinic Rochester, Rochester, Minnesota, USA
Debate: Bispecific Abs Are the Best Strategy for Relapsed DLBCL | Jennifer Crombie, MD | Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Novel Engineered NK Cell Trials | May Daher, MD | MD Anderson Cancer Center, Houston, Texas, USA
Oral Abstract TBA | Speaker | Affiliation, City, State, Country






Yi Lin, Mayo Clinic Rochester
Roni Shouval, Memorial Sloan Kettering Cancer Center
Jennifer Crombie, Dana-Farber Cancer Institute
Amin Turki, University of Essen
May Daher, MD Anderson Cancer Center